Table 3.

Influence of the synthetic compounds on ECG intervals QTc. Normal group referring to anesthesia group without any treatments, pre-dose group referring to BaCl₂-treated group and post-dose group referring to compounds-treated group.

Group	QTc (ms)
	Normal	Pre-Dose	Post-Dose
NS	0.10 ± 0.01	0.12 ± 0.02 **	0.12 ± 0.01 *
DMSO	0.11 ± 0.002	0.11 ± 0.01 **	0.12 ± 0.02
Ver (2 mg/kg)	0.10 ± 0.01	0.12 ± 0.02 **	0.12 ± 0.01 *
Scutellarein (8 mg/kg)	0.11 ± 0.01	0.12 ± 0.02 *	0.10 ± 0.01 ##▲▲
3 (8 mg/kg)	0.11 ± 0.01	0.12 ± 0.01 *	0.10 ± 0.01 #▲
7a (8 mg/kg)	0.10 ± 0.01	0.12 ± 0.02 *	0.10 ± 0.02 #▲
7b (8 mg/kg)	0.11 ± 0.01	0.13 ± 0.01 **	0.10 ± 0.01 #▲
7c (8 mg/kg)	0.11 ± 0.01	0.13 ± 0.01 **	0.11 ± 0.01
7d (8 mg/kg)	0.09 ± 0.004	0.12 ± 0.01 ***	0.09 ± 0.01 ###▲▲▲
7e (8 mg/kg)	0.10 ± 0.01	0.12 ± 0.01 **	0.09 ± 0.01 ##▲▲
7f (8 mg/kg)	0.11 ± 0.01	0.14 ± 0.01 **	0.11 ± 0.02
7g (8 mg/kg)	0.10 ± 0.01	0.13 ± 0.01 ***	0.10 ± 0.01 ##▲▲
8a (8 mg/kg)	0.09 ± 0.01	0.12 ± 0.01 ***	0.10 ± 0.01 ##▲
10a (8 mg/kg)	0.11 ± 0.01	0.13 ± 0.01 ***	0.11 ± 0.01 #▲
10b (8 mg/kg)	0.10 ± 0.01	0.12 ± 0.01 *	0.11 ± 0.01
10c (8 mg/kg)	0.10 ± 0.01	0.13 ± 0.01 **	0.10 ± 0.02
10d (8 mg/kg)	0.11 ± 0.01	0.12 ± 0.02 **	0.11 ± 0.01
10e (8 mg/kg)	0.10 ± 0.01	0.11 ± 0.01	0.10 ± 0.01 ##▲
10f (8 mg/kg)	0.09 ± 0.003	0.10 ± 0.02	0.10 ± 0.01 ##▲▲
11f (8 mg/kg)	0.09 ± 0.01	0.10 ± 0.03 *	0.10 ± 0.01 ##▲▲
12a (8 mg/kg)	0.10 ± 0.003	0.11 ± 0.01 *	0.10 ± 0.01 ##▲▲
13a (8 mg/kg)	0.11 ± 0.01	0.14 ± 0.01 ***	0.09 ± 0.01 *###▲▲▲
13b (8 mg/kg)	0.11 ± 0.002	0.10 ± 0.01 *	0.10 ± 0.01 #▲
14a (8 mg/kg)	0.10 ± 0.003	0.13 ± 0.01 **	0.09 ± 0.01 *###▲▲▲
14b (8 mg/kg)	0.10 ± 0.004	0.10 ± 0.01	0.09 ± 0.01 ###▲▲▲

Compared with Normal: * p < 0.05 ** p < 0.01 *** p < 0.001; Compared with NS: # p < 0.05 ## p < 0.01 ### p < 0.001; Compared with DMSO: ▲ p < 0.05 ▲▲ p < 0.01 ▲▲▲ p < 0.001; Data represent mean ± SD. n = 6.